D3VC.
September 2024

Deverra Therapeutics and EarthGrid

Written September 2024. Figures and statements were current as of that date and have not been updated.

We are excited to share that D3VC has made two strategic investments in August, further expanding our portfolio in the healthcare and energy sectors. Below are the details of the companies we have added to our growing list of investments.

1. Deverra Therapeutics. Industry: Healthcare, Biotechnology, and Life Sciences. Deverra Therapeutics is at the forefront of revolutionizing immune cell therapies for cancer and other life-threatening illnesses. Their lead asset, Dilanubicel, has shown promising results, significantly improving remission rates in leukemia patients during a Phase 2 clinical trial. Deverra is now on the cusp of a pivotal trial that could lead to FDA approval, targeting the $3.5B+ global acute myeloid leukemia market, and has been granted Fast Track designation. We also spoke with Prevail Partners, the venture group leading Deverra's post-crowdfund round, and were very impressed with their deep focus on life sciences, data-driven approach, and ability to expedite clinical trials toward FDA approval.

2. EarthGrid. Industry: Energy and Utilities. EarthGrid is redefining infrastructure with its vision of a global network of underground utility tunnels. These tunnels will carry clean energy, water, high-speed data, and e-commerce goods, all moved by a plasma-powered robot at a fraction of the cost and time of conventional methods. EarthGrid holds a patent for its plasma laser technology and currently has four purchase orders, with the first expected to close by the end of the year.

These investments align perfectly with D3VC's mission to leverage AI and data science to identify and support early-stage companies with the potential for venture-scale outcomes.

A positive outlook on venture capital returns

A recent PitchBook study of venture capital returns reported an annualized return of 25.5% for the period it covered. Past industry returns do not predict the results of any fund.

Investment crowdfunding: a groundbreaking financial innovation

We are proud to share that Investopedia recently ranked investment crowdfunding as one of the 25 groundbreaking financial innovations from the past 25 years. This recognition highlights the significant impact that crowdfunding has had on democratizing access to capital.

Seeking introductions to potential investors

As we continue to grow, we seek introductions to high-net-worth individuals, funds of funds investors, family offices, and others who might be interested in what we are doing. We would greatly appreciate your referrals if you know anyone who would be a good fit. As always, thank you for your continued support.